All NIH Funding Opportunities and Notices

• Request for Information (RFI): Inviting Scientific Interest in Geroscience Summit III
  (NOT-AG-18-011)
  National Institute on Aging
  

• NIAID Interest in Administrative Supplements to Address the Research Needed to Develop a Universal Influenza Vaccine
  (NOT-AI-18-030)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Correction to Award Information in PAR-18-246 Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)"
  (NOT-CA-18-064)
  National Cancer Institute
  

• Notice of Correction to Award Information in PAR-18-247 Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)"
  (NOT-CA-18-065)
  National Cancer Institute
  

• Notice of Change in Eligible Organizations in PA-18-748 Research Supplements to Promote Data Sharing in Cancer Epidemiology Studies (Admin Supp Clinical Trial Not Allowed)" to Allow Foreign Institutions.
  (NOT-CA-18-069)
  National Cancer Institute
  

• Presolicitation Notice: Request for Proposals (RFP) N01CN77019-18 "PREVENT Cancer Preclinical Drug Development Program: Preclinical Services for Biopharmaceutical Product Development and Manufacturing, Toxicology and Pharmacology Testing"
  (NOT-CA-18-070)
  National Cancer Institute
  

• Update in Funds Available and Anticipated Number of Awards , Award Budget and Award Project Period Sections of RFA-FD-08-018 - Development of a virtual bioequivalence trial simulation platform that integrates population pharmacokinetic modeling algorithms into physiologically-based pharmacokinetic models
  (NOT-FD-18-009)
  Food and Drug Administration
  

• Update in Funds Application Due Date(s) & Expiration Date Sections of RFA-FD-08-019 - Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems (U01)
  (NOT-FD-18-010)
  Food and Drug Administration
  

• Notice of NICHD Participation in NOT-AG-18-008 "Alzheimer's Disease and its related Dementias (AD/ADRD)-focused Administrative supplements for NIH grants that are not focused on Alzheimer's disease"
  (NOT-HD-18-010)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice to Extend the Expiration Date and Change Receipt Dates for PAR-16-458 "NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32)"
  (NOT-NS-18-061)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Availability of Administrative Supplements for Secondary Analysis of Existing Datasets within the Rare Diseases Clinical Research Network (RDCRN) to Explore Outcomes Relevant to Rare Diseases
  (NOT-TR-18-019)
  National Center for Advancing Translational Sciences
  National Heart, Lung, and Blood Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change to Application Due Date to PAR-18-244 "Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01)"
  (NOT-TR-18-023)
  National Center for Advancing Translational Sciences
  

• Notice of Change of Application Due Date to PAR-18-245 "Limited Competition: Exploratory CTSA Collaborative Innovation Awards (R21)"
  (NOT-TR-18-024)
  National Center for Advancing Translational Sciences
  

• Small Research Grant Program for the Next Generation of Clinical Researchers in Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (R03 Clinical Trial Optional)
  (RFA-AG-19-002)
  National Institute on Aging
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 3, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Small Research Grant Program for the Next Generation of Researchers in Basic Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed)
  (RFA-AG-19-003)
  National Institute on Aging
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 3, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required)
  (RFA-AI-18-015)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): September 27, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• SBIR E-learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
  (RFA-ES-18-006)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): July 31, 2018, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act
  (RFA-FD-18-013)
  Food and Drug Administration
  Application Receipt Date(s): June 25, 2018, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  

• Strengthen Regulatory Systems to Ensure the Safety and Quality of Food and Medical Products (U01)
  (RFA-FD-18-022)
  Food and Drug Administration
  Application Receipt Date(s): July 2, 2018, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  

• NIH Director's Pioneer Award (DP1 - Clinical Trial Optional)
  (RFA-RM-18-007)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 14, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
  

Past Tables of Contents

• (none)

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892